These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 6088713)

  • 1. Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis.
    Hanna C; Lawrie TA; Rogozińska E; Kernohan A; Jefferies S; Bulbeck H; Ali UM; Robinson T; Grant R
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013261. PubMed ID: 32202316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of radiation in treating glioblastoma: here to stay.
    Corso CD; Bindra RS; Mehta MP
    J Neurooncol; 2017 Sep; 134(3):479-485. PubMed ID: 28271281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolve.
    Koukourakis MI; Mitrakas AG; Giatromanolaki A
    Br J Cancer; 2016 Mar; 114(5):485-96. PubMed ID: 26889975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrosoureas in the Management of Malignant Gliomas.
    Brandes AA; Bartolotti M; Tosoni A; Franceschi E
    Curr Neurol Neurosci Rep; 2016 Feb; 16(2):13. PubMed ID: 26750128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for high-grade gliomas.
    Galanis E; Buckner J
    Br J Cancer; 2000 Apr; 82(8):1371-80. PubMed ID: 10780513
    [No Abstract]   [Full Text] [Related]  

  • 6. Dose-intensive, time-compressed procarbazine, CCNU, vincristine (PCV) with peripheral blood stem cell support and concurrent radiation in patients with newly diagnosed high-grade gliomas.
    Jakacki RI; Siffert J; Jamison C; Velasquez L; Allen JC
    J Neurooncol; 1999 Aug; 44(1):77-83. PubMed ID: 10582673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment modality for anaplastic oligodendroglioma: a phase II study.
    Jeremic B; Shibamoto Y; Gruijicic D; Milicic B; Stojanovic M; Nikolic N; Dagovic A; Aleksandrovic J
    J Neurooncol; 1999 Jun; 43(2):179-85. PubMed ID: 10533731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity reactions from antineoplastic agents.
    Weiss RB; Baker JR
    Cancer Metastasis Rev; 1987; 6(3):413-32. PubMed ID: 3319275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy for malignant gliomas of the brain: a review of ten-years experience.
    Paoletti P; Butti G; Knerich R; Gaetani P; Assietti R
    Acta Neurochir (Wien); 1990; 103(1-2):35-46. PubMed ID: 2360465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for high-grade malignant glioma: development of a prognostic index. A Report of the Medical Research Council Brain Tumour Working Party.
    J Neurooncol; 1990 Aug; 9(1):47-55. PubMed ID: 2213115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy.
    Mahaley MS
    J Neurooncol; 1991 Oct; 11(2):85-147. PubMed ID: 1744686
    [No Abstract]   [Full Text] [Related]  

  • 12. Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials.
    Curran WJ; Scott CB; Horton J; Nelson JS; Weinstein AS; Nelson DF; Fischbach AJ; Chang CH; Rotman M; Asbell SO
    J Neurooncol; 1992 Mar; 12(3):219-27. PubMed ID: 1583555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparisons of radiotherapy and carmustine versus procarbazine versus dacarbazine for the treatment of malignant gliomas following surgery: a Southwest Oncology Group Study.
    Eyre HJ; Eltringham JR; Gehan EA; Vogel FS; Al-Sarraf M; Talley RW; Costanzi JJ; Athens JW; Oishi N; Fletcher WS
    Cancer Treat Rep; 1986 Sep; 70(9):1085-90. PubMed ID: 3017551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled study with BCNU vs. CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme.
    Solero CL; Monfardini S; Brambilla C; Vaghi A; Valagussa P; Morello G; Bonadonna G
    Cancer Clin Trials; 1979; 2(1):43-8. PubMed ID: 229983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advantage of post-radiotherapy chemotherapy with CCNU, procarbazine, and vincristine (mPCV) over chemotherapy with VM-26 and CCNU for malignant gliomas.
    Jeremic B; Jovanovic D; Djuric LJ; Jevremovic S; Mijatovic LJ
    J Chemother; 1992 Apr; 4(2):123-6. PubMed ID: 1321239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
    Parasramka S; Talari G; Rosenfeld M; Guo J; Villano JL
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011773. PubMed ID: 28744879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic factors in malignant gliomas].
    Ushio Y; Kochi M
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):643-8. PubMed ID: 8678527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparisons of radiotherapy and CCNU versus radiotherapy, CCNU plus procarbazine for the treatment of malignant gliomas following surgery. A Southwest Oncology Group Report.
    Eyre HJ; Quagliana JM; Eltringham JR; Frank J; O'Bryan RM; McDonald B; Rivkin SE
    J Neurooncol; 1983; 1(3):171-7. PubMed ID: 6088713
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.